P

Inventor

Kozak Jennifer

US17 patents
⚠️ This page may combine multiple inventors who share the name “Kozak Jennifer”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THERAVANCE BIOPHARMA R&D IP LLC

16 patents
US10028960B2Jul 24, 2018

Pyrimidine compounds as JAK kinase inhibitors

THERAVANCE BIOPHARMA R&D IP LLC18 citations93
US9725470B2Aug 8, 2017

Substituted naphthyridines as JAK kinase inhibitors

THERAVANCE BIOPHARMA R&D IP LLC27 citations93
US10308646B2Jun 4, 2019

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC11 citations92
US11420965B2Aug 23, 2022

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10774080B2Sep 15, 2020

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC5 citations84
US10562894B2Feb 18, 2020

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC7 citations84
US11780852B2Oct 10, 2023

Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile

THERAVANCE BIOPHARMA R&D IP LLC3 citations83
US10947254B2Mar 16, 2021

Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile

THERAVANCE BIOPHARMA R&D IP LLC3 citations83
US11110095B2Sep 7, 2021

Pyrimidine compounds as JAK kinase inhibitors

THERAVANCE BIOPHARMA R&D IP LLC3 citations72
US10952996B2Mar 23, 2021

ALK5 inhibitors

THERAVANCE BIOPHARMA R&D IP LLC2 citations71
US12358931B2Jul 15, 2025

3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US12172994B2Dec 24, 2024

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11814377B2Nov 14, 2023

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11730720B2Aug 22, 2023

ALK5 inhibitors

THERAVANCE BIOPHARMA R&D IP LLC0 citations60
US11590116B2Feb 28, 2023

Substituted pyridines and methods of use

THERAVANCE BIOPHARMA R&D IP LLC1 citations60
US11673879B2Jun 13, 2023

Substituted pyrimidines and methods of use

THERAVANCE BIOPHARMA R&D IP LLC0 citations50

THERAVANCE BIOPHARMA R & D IP LLC

1 patent